New Gut-Targeted pill aims to calm bowel disease flares
NCT ID NCT04276740
Summary
This study is testing whether a daily capsule called MitoQ can help people with a flare-up of moderate ulcerative colitis. About 80 participants will take either MitoQ or a placebo (dummy pill) for 24 weeks alongside standard steroid treatment. Researchers want to see if MitoQ, which protects the energy-producing parts of gut cells, reduces inflammation, improves symptoms, and helps patients stay in remission without needing stronger medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS FLARE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NHS Lothian
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.